Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

August 10, 2017
August 10, 2017

Share

AMR (acquired by Stax in 2022) assisted Provimi in making a major strategic move into the Mexican animal feed market.


Client and project overview

Provimi, a major European animal nutrition business, wanted to build a presence in the Mexican market and had identified a potential acquisition target. AMR was asked to provide input on the achievability of the business plan in light of numerous risk factors.


Key questions

  • What is the structure of the Mexican animal feed market and how is it changing (including industrialization)?
  • How have external factors impacted the target’s performance?
  • What are the target’s sources of competitive advantage and how sustainable are there?


Highlights of methodology

  • Developed a sophisticated understanding of the external factors influencing the target’s performance, including underlying demand, industrialization, macro shocks, regional variation and competition
  • We combined this with a thorough review of the target’s internal data (including pricing) and customer base


Results

  • Our work proved critical to allowing the deal to go ahead, based on the key finding that recent volatility in the target’s performance was caused by one-off, external factors and the underlying performance was highly stable
  • Our analysis of customer preferences also identified clear value-creation potential
  • Based on clear recommendations from AMR, the business was able to perform significantly ahead of budget in year one


“The sale of Provimi is the culmination of a four-year project to reshape the business and maximize shareholder value. AMR played a critical role in supporting Provimi as we realized this vision, and helped provide valuable support in the course of a smooth and well-run transaction.” (Provimi)

Read More

Featured by Bezinga: Health Care PE Is ‘No Longer An Easy Source Of Returns'
October 8, 2026
Rob Larson was featured by Bezinga, offering his expert insights on the current state of healthcare within PE and why investments continue to be made in the industry, Read more.
What Local Governments Need from GovTech Right Now: Lessons from CivStart
By Chen Liu • October 1, 2026
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax Top 20 2025
By Florent Jarry & David Lindsay • September 17, 2026
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Feat. by Pitchbook: The future of diligence is not integration. It is conviction.
By Paul Edwards • September 15, 2026
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Featured by Carta: PE is trying to figure out where AI fits into the future of healthcare
By Rob Larson • September 8, 2026
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax  Sell-side: Outcomes Strategic Investment From H.I.G. Capital
September 2, 2026
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.
Show More